Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/29/20 → 12/31/23 |
Funding
- Novartis Pharmaceuticals Corporation: $114,829.25
PARAGLIDE-HF: A Multicenter Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Valsartan on Changes in NT-proBNP, Safety, and Tolerability in HF...
- Skopicki, Hal A (PI)
- Chen, On (CoPI)
- Lawson, William (CoPI)
- Bloom, Michelle (CoPI)
- Reilly, Peter (CoPI)
- Borriello, Caitlin (CoI)
- Pilato, Lauren (CoI)
Project: Research